Important: Please Read Disclosure.
Go to Capital Exchange HQ to open an account now!




   

Forums > Triple A Lindex Trading




Created Subject By Replies Last Reply
Jan 10th 2012, 09:39 Financial Reports - For CEO Posting Only   Skip Oceanlane  7 Apr 21st, 08:30
Anthonius Berkmans
Feb 6th, 05:11 News Story: Buy back started   Anthonius Berkmans  15 Apr 21st, 15:58
Anthonius Berkmans
Dec 8th 2012, 15:53 Future buyback policy   Anthonius Berkmans  8 Dec 11th 2012, 10:50
Stroh Bing
Aug 25th 2012, 16:53 TALT business aspects. NAV L$0.98/share.   Stryker Yoshikawa  7 Sep 1st 2012, 22:26
Skip Oceanlane
Aug 10th 2012, 22:21 Why dividents so low?   Imbanna Ghanduhar  2 Aug 25th 2012, 08:28
Anthonius Berkmans
Jul 23rd 2012, 12:28 Update and financial report?   Stryker Yoshikawa  2 Jul 31st 2012, 03:25
Anthonius Berkmans
May 24th 2012, 05:35 Divident   Anthonius Berkmans  1 May 24th 2012, 05:35
Anthonius Berkmans
Apr 28th 2012, 01:30 I lost 10000 on this shares   Imbanna Ghanduhar  5 May 5th 2012, 03:56
Alain Delpiaz
Feb 24th 2012, 03:41 News Story: First month prediction   Anthonius Berkmans  1 Feb 24th 2012, 03:41
Anthonius Berkmans
Jan 31st 2012, 07:04 Triple A Lindex Trading (TALT) IPO Sold Out, Open Trading Started   Skip Oceanlane  5 Feb 1st 2012, 06:56
Skip Oceanlane
Jan 30th 2012, 05:25 Triple A Lindex Trading (TALT) IPO Has Started   Skip Oceanlane  3 Jan 30th 2012, 15:47
Macbeth Kingmaker
Jan 23rd 2012, 15:40 Triple A Lindex Trading (TALT) IPO Starts Monday, Jan 30, 5:00 AM SLT   Skip Oceanlane  1 Jan 23rd 2012, 15:40
Skip Oceanlane
Jan 10th 2012, 09:38 IPO Application Approved - Triple A Lindex Trading (TALT)   Skip Oceanlane  1 Jan 10th 2012, 09:38
Skip Oceanlane
Jan 7th 2012, 13:19 IPO Application Submitted - Triple A Lindex Trading (TALT)   Skip Oceanlane  6 Jan 7th 2012, 23:18
NintaiBrokerage Resident





This website © 2008-2013 Capital Exchange (CapEx). All rights reserved.
Second Life, SL, and inSL are trademarks of Linden Research, Inc. Capital Exchange (CapEx) is not affiliated with or sponsored by Linden Research.